Einde inhoudsopgave
Implementing Regulations to the European Patent Convention
Rule 28 Exceptions to patentability
Geldend
Geldend vanaf 01-07-2017
- Redactionele toelichting
Deze wijziging is van toepassing op Europese octrooiaanvragen ingediend op of na 01-01-2017, alsmede op dat tijdstip aanhangige Europese octrooiaanvragen en Europese octrooien.
- Bronpublicatie:
29-06-2017, Trb. 2017, 130 (uitgifte: 14-08-2017, regelingnummer: CA/D 6/17)
- Inwerkingtreding
01-07-2017
- Bronpublicatie inwerkingtreding:
29-06-2017, Trb. 2017, 130 (uitgifte: 14-08-2017, regelingnummer: CA/D 6/17)
- Vakgebied(en)
Intellectuele-eigendomsrecht / Octrooirecht
Internationaal privaatrecht / Bijzondere onderwerpen
1.
Under Article 53(a), European patents shall not be granted in respect of biotechnological inventions which, in particular, concern the following:
- (a)
processes for cloning human beings;
- (b)
processes for modifying the germ line genetic identity of human beings;
- (c)
uses of human embryos for industrial or commercial purposes;
- (d)
processes for modifying the genetic identity of animals which are likely to cause them suffering without any substantial medical benefit to man or animal, and also animals resulting from such processes.
2.
Under Article 53(b), European patents shall not be granted in respect of plants or animals exclusively obtained by means of an essentially biological process.